home / stock / achv / achv news

ACHV News and Press, Achieve Life Sciences Inc. From 04/02/20

Stock Information
Company Name: Achieve Life Sciences Inc.
Stock Symbol: ACHV
Market: NASDAQ
Website: achievelifesciences.com
Menu
ACHV ACHV Quote ACHV Short ACHV News ACHV Articles ACHV Message Board
Get ACHV Alerts

News, Short Squeeze, Breakout and More Instantly...
ACHV - Seasoned Biotech Financial Executive, Jay M. Moyes, Joins Sera Prognostics

- Will support Sera’s Transition from clinical to commercial stage company - - Sera positioned for growth with several outcome study read-outs taking place in 2020 - SALT LAKE CITY, April 02, 2020 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., The Pregnancy Company...
ACHV - Achieve Life Sciences, Inc.'s (ACHV) CEO Richard Stewart on Q4 2019 Results - Earnings Call Transcript

Achieve Life Sciences, Inc. (ACHV) Q4 2019 Results Earnings Conference Call March 13, 2020, 08:30 AM ET Company Participants Jaime Xinos - Executive Vice President of Commercial Richard Stewart - Chief Executive Officer John Bencich - Chief Financial Officer Cindy Jacobs - Exec...

ACHV - Achieve Life Sciences +11% Q4 results

Achieve Life Sciences ( ACHV ) Q4 results : Revenues: $0; Net loss: ($3.2M) (+11.1%); loss/share: ($0.30) (+45.5%). More news on: Achieve Life Sciences, Inc., Healthcare stocks news, Stocks on the move, Earnings news and commentary, , Read more ...

ACHV - Achieve Life Sciences EPS beats by $0.02

Achieve Life Sciences (NASDAQ: ACHV ): Q4 GAAP EPS of -$0.30 beats by $0.02 . More news on: Achieve Life Sciences, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , Read more ...

ACHV - Achieve Reports Financial Results for Fourth Quarter and Year-End 2019 and Provides Update on Cytisinicline Development Program

SEATTLE and VANCOUVER, British Columbia , March 13, 2020 /PRNewswire/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, toda...

ACHV - Achieve Life Sciences Announces Presentation of Additional Cytisinicline Analyses at the Society for Research on Nicotine & Tobacco (SRNT) Annual Meeting

SEATTLE and VANCOUVER, British Columbia , March 12, 2020 /PRNewswire/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, announ...

ACHV - Achieve Life Sciences Announces Agreement with the FreeMind Group to Assist in Securing Non-Dilutive Funding to Evaluate Cytisinicline in Vaping and e-Cigarette Users

SEATTLE and VANCOUVER, British Columbia , Feb. 6, 2020 /PRNewswire/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today ...
ACHV - Oracle cloud improves speed of drug discovery

Achieve Life Sciences (NASDAQ: ACHV ), University of Bristol, and Oracle (NYSE: ORCL ) announce the outcome of a study using Oracle's cloud infrastructure to improve the speed of drug discovery and development of new treatments. More news on: Achieve Life Sciences, Inc., Oracle Corporati...

ACHV - Achieve Life Sciences, University of Bristol, and Oracle Corporation Announce Study Results Demonstrating Potential for Accelerated Speed of Drug Discovery

SEATTLE and VANCOUVER, British Columbia , Jan. 13, 2020 /PRNewswire/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), University of Bristol , and Oracle Corporation (NYSE: ORCL) today announced the outcome of a study using Oracle's high-performance cloud infrastructure to potentiall...

ACHV - Achieve Life Sciences, Inc. Announces Closing of $13.8 Million Underwritten Public Offering, Including Full Exercise of Overallotment Option

Achieve Life Sciences, Inc. Announces Closing of $13.8 Million Underwritten Public Offering, Including Full Exercise of Overallotment Option Canada NewsWire SEATTLE and VANCOUVER, British Columbia, Dec. 19, 2019 SEATTLE and VANCOUVER, British Columbia , Dec. 19, 2019 ...
Previous 10 Next 10